CA
FBIO icon

Cliff Asness’s Fortress Biotech FBIO Stock Holding History

Cliff Asness’s Portfolio FBIO Stock Details FBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-3,903
Closed -$207K – 2250
2021
Q1 		$207K Sell
3,903
-714
-15% -$40.3K ﹤0.01% 2104
2020
Q4 		$220K Hold
4,617
– – ﹤0.01% 2062
2020
Q3 		$280K Buy
+4,617
New +$235K ﹤0.01% 1941
2015
Q4 		– Sell
-1,037
Closed -$40K – 2256
2015
Q3 		$40K Sell
1,037
-1,207
-54% -$56.4K ﹤0.01% 2146
2015
Q2 		$113K Buy
+2,244
New +$115K ﹤0.01% 2159
2014
Q3 		– Sell
-1,907
Closed -$49K – 2536
2014
Q2 		$49K Sell
1,907
-9,120
-83% -$240K ﹤0.01% 2496
2014
Q1 		$327K Buy
11,027
+9,514
+629% +$371K ﹤0.01% 2227
2013
Q4 		$60K Buy
+1,513
New +$58.4K ﹤0.01% 2544

Other funds holding FBIO

NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
SAM
Shikiar Asset Management New York $396M AUM 41.06% 1-Year Est. Return
CL
CPWM LLC Seattle, Washington $1.06B AUM 14.49% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Cliff Asness's FBIO Position: Q2 2021 in Review

Cliff Asness sold out of Fortress Biotech (FBIO) in Q2 2021, closing a stake of 3,903 shares — an estimated $207K sold.

Cliff Asness first reported a position in FBIO in Q4 2013 and held it in 8 quarters. The position peaked at $327K in Q1 2014. 84 funds tracked by Wall St. Rank hold FBIO as of Q2 2021.

  • Cliff Asness reported no remaining Fortress Biotech position as of Q2 2021 after selling out during the quarter.
  • Cliff Asness sold 3,903 Fortress Biotech shares in Q2 2021, an estimated $207K.
  • Cliff Asness first reported a position in Fortress Biotech in Q4 2013 and held it in 8 quarters.
  • Cliff Asness's Fortress Biotech position peaked at $327K in Q1 2014.
  • 84 funds tracked by Wall St. Rank held Fortress Biotech as of Q2 2021.

Based on AQR Capital Management's 13F filing for Q2 2021, filed 16 Aug 2021.